Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

NCT01918644 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Stage IA Pancreatic Cancer
Stage IB Pancreatic Cancer
Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer

Interventions

RADIATION: stereotactic body radiation therapy
DRUG: capecitabine
PROCEDURE: therapeutic conventional surgery
PROCEDURE: magnetic resonance imaging
OTHER: laboratory biomarker analysis

Sponsor

University of Wisconsin, Madison